No Data
Fosun Pharma (301371): Income growth accelerates, reorganization progresses on three categories of collagen medical devices.
In the third quarter of 2024, the company achieved revenue of 0.527 billion yuan, an 11.88% year-on-year increase, and achieved a net income attributable to the parent company of 0.173 billion yuan, a 5.16% year-on-year decline. In the third quarter, the company maintained its two.
Fulijia (301371): Q3 revenue 0.527 billion, YOY +11.88%, steady growth.
Event: The company released its third quarter report for 2024. The revenue for Q1-Q3 of 2024 was 1.466 billion, with a year-on-year increase of 9.47%; the net profit attributable to the parent company was 0.514 billion yuan, a year-on-year decrease of 4.2%. In Q3 of 2024, the company achieved revenue of 5.
Fusion Tech (301371): Steady growth in Q3 revenue. Freeze-dried fibers completed clinical filing, taking the first step in medical aesthetics.
Event: For the third quarter of 2024, Fuli Jia disclosed its performance: Q1-3 2024: revenue of 1.466 billion yuan, +9%, net income attributable to shareholders of 0.514 billion yuan, -4%. Q3 2024: revenue of 0.527 billion yuan, +12%, net income attributable to shareholders
Fujia (301371): Performance meets expectations, bullish on strong research and development driving rapid introduction of new products.
Investment Highlights Q3 Revenue growth accelerated on a month-on-month basis, performance met expectations: (1) 24Q1-Q3: achieved revenue of 1.466 billion, +9.47% year-on-year, gross margin of 81.65%, slightly decreased by 0.73 percentage points year-on-year, selling expenses.
Express News | Fu Er Jia: The november 11 shopping festival-related event layout has been completed.
Fosun Pharma (301371): Steady revenue growth, promising future in the pipeline under research.
Event: The company released the third quarter report of 2024: In 2024Q1-Q3, the company achieved revenue of 1.466 billion yuan, +9.47% year-on-year, achieved a net income attributable to mother of 0.514 billion yuan, -4.20% year-on-year, achieving a non-net income.
No Data
No Data